What is nephrotic syndrome, including its risk factors, patient presentation, physical exam findings, and laboratory results?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nephrotic Syndrome: Overview, Risk Factors, Presentation, and Laboratory Findings

Nephrotic syndrome is characterized by the triad of nephrotic-range proteinuria (>3.5g/24h), hypoalbuminemia (<30g/L), and edema, often accompanied by hyperlipidemia and increased risk of thromboembolism. 1, 2

Definition and Pathophysiology

  • Nephrotic syndrome results from increased glomerular permeability to proteins due to podocyte dysfunction, leading to substantial protein loss in urine 1
  • The primary pathophysiological mechanism involves alterations in the glomerular filtration barrier, allowing proteins (primarily albumin) to leak into the urine 3
  • Loss of albumin leads to decreased oncotic pressure, causing fluid shift from intravascular to interstitial spaces, resulting in edema 1
  • Hyperlipidemia occurs as a compensatory mechanism for the loss of plasma proteins 1

Risk Factors and Etiology

  • Primary (idiopathic) causes:

    • Minimal change disease (most common in children) 2
    • Focal segmental glomerulosclerosis (most common in African ancestry populations) 2
    • Membranous nephropathy (most common in white adults) 2
  • Secondary causes:

    • Diabetes mellitus (most common systemic cause) 2
    • Systemic lupus erythematosus 2
    • Amyloidosis 4
    • Infections 5
    • Medications 5
    • Genetic disorders (particularly in congenital nephrotic syndrome) 6
  • Genetic factors:

    • Congenital nephrotic syndrome is primarily caused by genetic defects in podocytes 6
    • Common genetic mutations include NPHS1 (encoding nephrin), NPHS2 (encoding podocin), WT1, and PLCE1 6

Clinical Presentation

  • Edema:

    • Periorbital edema (most noticeable in the morning) 2
    • Dependent pitting edema (more common later in the day) 2
    • Can progress to involve limbs and abdomen with severe disease 4
  • Other symptoms:

    • Fatigue 3
    • Decreased urine output 4
    • Weight gain due to fluid retention 5
  • Physical examination findings:

    • Pitting edema (periorbital, lower extremities, sacral, abdominal) 4
    • Pleural effusions and ascites in severe cases 5
    • Hypertension (may be present in some cases) 1

Laboratory Findings

  • Urinary findings:

    • Proteinuria >3.5g/24h (measured by 24-hour urine collection) 2
    • Protein:creatinine ratio (PCR) >300-350 mg/mmol indicates nephrotic range proteinuria 2
    • Lipiduria (oval fat bodies, fatty casts) 2
  • Serum findings:

    • Hypoalbuminemia (<30 g/L, often <20 g/L in severe cases) 2
    • Hyperlipidemia (elevated total cholesterol, LDL, triglycerides) 4
    • Normal or mildly elevated serum creatinine (unless complicated by acute kidney injury) 2
  • Other laboratory abnormalities:

    • Low levels of binding proteins for ions, vitamins, hormones 7
    • Altered coagulation profile (loss of anticoagulant proteins) 7
    • Vitamin D deficiency 5

Complications

  • Thromboembolism:

    • High risk of venous thrombosis (29% for renal vein thrombosis, 17-28% for pulmonary embolism) 1
    • Due to loss of anticoagulant proteins and increased procoagulant factors 7
  • Infections:

    • Increased susceptibility due to loss of immunoglobulins and complement factors 5
    • Common sites include skin, respiratory tract, and urinary tract 7
  • Acute kidney injury:

    • Can occur due to hypovolemia, nephrotoxic medications, or progression of underlying disease 7
  • Progression to chronic kidney disease:

    • Patients with nephrotic-range proteinuria >3.8g/day have a 35% risk of end-stage renal disease within 2 years 1

Diagnostic Approach

  • Quantitative measurement of proteinuria (24-hour collection or spot urine protein/creatinine ratio) 2
  • Serum albumin, lipid profile, and renal function tests 2
  • Referral to a nephrologist is necessary (ideally within 2 weeks) 2
  • Renal biopsy is usually performed to establish the specific form of glomerular disease 2
  • Additional tests to identify secondary causes (e.g., diabetes, lupus, amyloidosis) 2

References

Guideline

Nephrotic and Nephritic Syndrome Mechanisms and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nephrotic Syndrome: A Review.

Cureus, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.